Nevia Bio
PrivateLast Round
Seed
Aug 29, 2023
Total Funding Raised
$5M
Company Overview
Nevia Bio is a biotechnology company that develops AI-powered diagnostic platforms for the early detection of gynecological cancers, with an initial focus on ovarian cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical AI, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nevia Bio Comparables
Compare Nevia Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AOA Dx | 84% | |
| InterVenn Biosciences | 77% | |
| ClearNote Health | 74% | |
Nevia Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 29, 2023 |
Nevia Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AMIT Technion | Seed |
| MindUP | Seed |
| ALIVE Israel HealthTech Fund | Seed |
Nevia Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nevia Bio's valuation, stock price, and market status.